Drug Approval | June 15, 2023
Granules India receives ANDA approval for Levetiracetam Tablets
Granules now has a total of 58 ANDA approvals from US FDA
Granules now has a total of 58 ANDA approvals from US FDA
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
The product is expected to be launched in June 2023
For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
Testing supporting allergy diagnosis now accessible to more people in more communities
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
The Theme of the event was 'Building One Health Together – Improving Health Equity'
Subscribe To Our Newsletter & Stay Updated
